ClinicalTrials.gg
Status unknownNCT01216462NET-SCAUpdated May 21, 2015

Registry of Acute Coronary Syndromes in the Lazio Region of Italy

An observational study in Acute Coronary Syndromes, sponsored by San Filippo Neri General Hospital. Status unknown at 8 sites in Italy. Per ClinicalTrials.gov, last updated 2015-05-21.

Sponsored by San Filippo Neri General Hospital · Observational

The sponsor has not verified this record recently (last verified May 2015), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
3,000
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 138 studies in Acute Coronary Syndrome with a site in Italy — 25 open to participants now, 30 under way, 2 of them phase 3. Acute Coronary Syndrome · Italy.

Planned enrollment
12th of 52
3,000 · median 1,000
Started
2010
with 10 others
Observational
53 of 138
13 open now
Registered
31st of 138
by date

Among the 138 studies in Acute Coronary Syndrome with a site in Italy, this one is the 12th largest by planned enrollment of the 52 observational ones that give a count, is one of 11 that started in 2010, is one of 53 observational ones, and was the 31st registered.

Acute Coronary Syndrome

1,489 studies on the registry are indexed under Acute Coronary Syndrome; 271 are open to participants now.

Browse Acute Coronary Syndrome studies →

Open to participants now

25 of the 138 studies in Acute Coronary Syndrome with a site in Italy are open now. Recruiting first, the newest first:

20 more — sign in →

All 25 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 195 Acute Coronary Syndrome studies recruiting now, 144 (74%) set no upper age limit and 19 (10%) stop at 75 or younger; 14 take children under 18; 15 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 138 studies in Acute Coronary Syndrome with a site in Italy, or all of them as a file.
02

Study summary

The NET-SCA Registry has been designed to document and evaluate the clinical epidemiology and current management of Acute Coronary Syndromes in the Lazio Region of Italy.

Read the detailed description

Lazio is a region of central Italy with a resident population of about 5,600,000. The NET-SCA Registry has been designed to document and evaluate the current presentation and clinical management of Acute Coronary Syndromes (ACS) in this specific regional area of Italy. All consecutive patients with ACS admitted to CCU of 15 hospitals of the Lazio Region will be included in the registry.

03

Conditions studied

  • Acute Coronary Syndromes

Keywords

  • Acute Coronary Syndrome
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Consecutive patients with ACS admitted to CCU of 15 hospitals of the Lazio Region of Italy.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • admission to CCU for ACS

Exclusion criteria

Exclusion Criteria:

  • ACS due to major extracardiac causes (i.e. traumatic)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
3,000 participants (estimated)
Biospecimen retention
Samples with dna
06

What researchers measure

Primary outcomes

  1. Total Mortality

    Time frame: 12 months

Secondary outcomes

  1. Cardiovascular Mortality

    Time frame: 12 months

  2. New admissions of ACS

    Time frame: 12 months

  3. New admissions for heart failure

    Time frame: 12 months

  4. New admissions for coronary revascularization

    Time frame: 12 months

07

Study locations

8 of 8 sites recruiting
  • Ospedale GG Grassi
    Ostia, Roma 00125, Italy
    Recruiting
    • Fabrizio Ammirati, MD · Contactfabammirati@alice.it
    • Fabrizio Ammirati, MD · Principal investigator
  • Ospedale "G.B. Grassi"
    Rome, 00122, Italy
    Recruiting
  • San Filippo Neri Hospital
    Rome, 00135, Italy
    Recruiting
  • Ospedale "S. Eugenio"
    Rome, 00144, Italy
    Recruiting
  • Ospedale "Sandro Pertini"
    Rome, 00157, Italy
    Recruiting
  • Policlinico Casilino
    Rome, 00169, Italy
    Recruiting
  • Ospedale "Madre Giuseppina Vannini"
    Rome, 00177, Italy
    Recruiting
  • Ospedale FBF "Isola Tiberina"
    Rome, 00186, Italy
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2010, a primary completion of Dec 2016 and a completion of Dec 2018. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 6, 2010
First posted
Oct 7, 2010
Start
Jan 2010
Primary completionEst.
Dec 2016
CompletionEst.
Dec 2018
Last update
May 21, 2015
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 21, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01216462
Lead sponsor
San Filippo Neri General Hospital
Collaborators
Associazione Nazionale Medici Cardiologi Ospedalieri
Responsible party
Furio Colivicchi (Director, Division of Cardiology, San Filippo Neri General Hospital, Rome, ITALY, San Filippo Neri General Hospital) — Principal investigator
First posted
Oct 7, 2010
Start date
Jan 2010
Primary completion
Dec 2016 (estimated)
Completion
Dec 2018 (estimated)
Last update
May 21, 2015

Study contacts

Furio Colivicchi, MD
Contact
f.colivicchi@sanfilipponeri.roma.it
+39.06.3306.1 ext. 2429
Marco Tubaro, MD
Contact
m.tubaro@sanfilipponeri.roma.it
+39.06.3306.1 ext. 2467
Furio Colivicchi, MD
principal investigator · San Filippo Neri Hospital, Rome, Italy

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion